Skip to main content
NeuronFeed

Nabla Bio vs Recursion

Which Drug Discovery AI tool is better in 2026?

Nabla Bio

Generative AI for de novo antibody and protein design against tough drug targets

$37M

Recursion

Pioneering AI-driven solutions in drug discovery to radically improve lives.

$500M

Side-by-side

Verdict

Recursion is the more established option (raised $500M); pricing is comparable on both sides.

Metric Nabla Bio Recursion
Taglinei Generative AI for de novo antibody and protein design against tough drug targets Pioneering AI-driven solutions in drug discovery to radically improve lives.
Foundedi 2021 2013🏆
HQi Boston, US Salt Lake City, US
Employeesi 11-50 501-1000🏆
Neuron scorei 49 66🏆
Total fundingi $37M $500M🏆
Latest roundi Series A IPO · Apr 2021
Valuationi $2B🏆
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Free Enterprise · Contact sales
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Nabla Bio and Recursion.

Capability Nabla Bio Recursion
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Nabla Bio

  • Offers a free plan
  • Offers a free trial
  • Newer company (2021)

🔵 Strengths of Recursion

  • Has raised more capital ($500M vs $37M)
  • Higher Neuron score (66 vs 49)
  • More mature (2013)

Which should you choose?

Choose Recursion if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Recursion if you want the most established option — it has raised $500M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Nabla Bio vs Recursion — which is better?

It depends on your priority. Nabla Bio is the leaner option; Recursion has broader feature depth. See the side-by-side table above.

Is Nabla Bio cheaper than Recursion?

No — Recursion's cheapest paid plan is Enterprise · Contact sales, while Nabla Bio's is Free.

Do Nabla Bio and Recursion offer free plans?

Nabla Bio: Yes, has a free plan. Recursion: Paid only.

Contextual paths to related AI startups, deals and rankings.